Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
18,515
archived clinical trials in
Lymphoma

Cladribine in Patients With Mantle Cell Lymphoma
A PHASE II TRIAL OF 2-CDA IN PREVIOUSLY TREATED OR UNTREATED PATIENTS WITH MANTLE CELL LYMPHOMA (MCL)
Status: Enrolling
Updated:  7/7/2015
CCOP - Ann Arbor Regional
mi
from
Ann Arbor, MI
Cladribine in Patients With Mantle Cell Lymphoma
A PHASE II TRIAL OF 2-CDA IN PREVIOUSLY TREATED OR UNTREATED PATIENTS WITH MANTLE CELL LYMPHOMA (MCL)
Status: Enrolling
Updated: 7/7/2015
CCOP - Ann Arbor Regional
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Cladribine in Patients With Mantle Cell Lymphoma
A PHASE II TRIAL OF 2-CDA IN PREVIOUSLY TREATED OR UNTREATED PATIENTS WITH MANTLE CELL LYMPHOMA (MCL)
Status: Enrolling
Updated:  7/7/2015
CCOP - Duluth
mi
from
Duluth, MN
Cladribine in Patients With Mantle Cell Lymphoma
A PHASE II TRIAL OF 2-CDA IN PREVIOUSLY TREATED OR UNTREATED PATIENTS WITH MANTLE CELL LYMPHOMA (MCL)
Status: Enrolling
Updated: 7/7/2015
CCOP - Duluth
mi
from
Duluth, MN
Click here to add this to my saved trials
Cladribine in Patients With Mantle Cell Lymphoma
A PHASE II TRIAL OF 2-CDA IN PREVIOUSLY TREATED OR UNTREATED PATIENTS WITH MANTLE CELL LYMPHOMA (MCL)
Status: Enrolling
Updated:  7/7/2015
Mayo Clinic Cancer Center
mi
from
Rochester, MN
Cladribine in Patients With Mantle Cell Lymphoma
A PHASE II TRIAL OF 2-CDA IN PREVIOUSLY TREATED OR UNTREATED PATIENTS WITH MANTLE CELL LYMPHOMA (MCL)
Status: Enrolling
Updated: 7/7/2015
Mayo Clinic Cancer Center
mi
from
Rochester, MN
Click here to add this to my saved trials
Cladribine in Patients With Mantle Cell Lymphoma
A PHASE II TRIAL OF 2-CDA IN PREVIOUSLY TREATED OR UNTREATED PATIENTS WITH MANTLE CELL LYMPHOMA (MCL)
Status: Enrolling
Updated:  7/7/2015
CentraCare Clinic
mi
from
Saint Cloud, MN
Cladribine in Patients With Mantle Cell Lymphoma
A PHASE II TRIAL OF 2-CDA IN PREVIOUSLY TREATED OR UNTREATED PATIENTS WITH MANTLE CELL LYMPHOMA (MCL)
Status: Enrolling
Updated: 7/7/2015
CentraCare Clinic
mi
from
Saint Cloud, MN
Click here to add this to my saved trials
Cladribine in Patients With Mantle Cell Lymphoma
A PHASE II TRIAL OF 2-CDA IN PREVIOUSLY TREATED OR UNTREATED PATIENTS WITH MANTLE CELL LYMPHOMA (MCL)
Status: Enrolling
Updated:  7/7/2015
CCOP - Missouri Valley Cancer Consortium
mi
from
Omaha, NE
Cladribine in Patients With Mantle Cell Lymphoma
A PHASE II TRIAL OF 2-CDA IN PREVIOUSLY TREATED OR UNTREATED PATIENTS WITH MANTLE CELL LYMPHOMA (MCL)
Status: Enrolling
Updated: 7/7/2015
CCOP - Missouri Valley Cancer Consortium
mi
from
Omaha, NE
Click here to add this to my saved trials
Cladribine in Patients With Mantle Cell Lymphoma
A PHASE II TRIAL OF 2-CDA IN PREVIOUSLY TREATED OR UNTREATED PATIENTS WITH MANTLE CELL LYMPHOMA (MCL)
Status: Enrolling
Updated:  7/7/2015
Quain & Ramstad Clinic, P.C.
mi
from
Bismarck, ND
Cladribine in Patients With Mantle Cell Lymphoma
A PHASE II TRIAL OF 2-CDA IN PREVIOUSLY TREATED OR UNTREATED PATIENTS WITH MANTLE CELL LYMPHOMA (MCL)
Status: Enrolling
Updated: 7/7/2015
Quain & Ramstad Clinic, P.C.
mi
from
Bismarck, ND
Click here to add this to my saved trials
Cladribine in Patients With Mantle Cell Lymphoma
A PHASE II TRIAL OF 2-CDA IN PREVIOUSLY TREATED OR UNTREATED PATIENTS WITH MANTLE CELL LYMPHOMA (MCL)
Status: Enrolling
Updated:  7/7/2015
CCOP - Merit Care Hospital
mi
from
Fargo, ND
Cladribine in Patients With Mantle Cell Lymphoma
A PHASE II TRIAL OF 2-CDA IN PREVIOUSLY TREATED OR UNTREATED PATIENTS WITH MANTLE CELL LYMPHOMA (MCL)
Status: Enrolling
Updated: 7/7/2015
CCOP - Merit Care Hospital
mi
from
Fargo, ND
Click here to add this to my saved trials
Cladribine in Patients With Mantle Cell Lymphoma
A PHASE II TRIAL OF 2-CDA IN PREVIOUSLY TREATED OR UNTREATED PATIENTS WITH MANTLE CELL LYMPHOMA (MCL)
Status: Enrolling
Updated:  7/7/2015
Altru Health Systems
mi
from
Grand Forks, ND
Cladribine in Patients With Mantle Cell Lymphoma
A PHASE II TRIAL OF 2-CDA IN PREVIOUSLY TREATED OR UNTREATED PATIENTS WITH MANTLE CELL LYMPHOMA (MCL)
Status: Enrolling
Updated: 7/7/2015
Altru Health Systems
mi
from
Grand Forks, ND
Click here to add this to my saved trials
Cladribine in Patients With Mantle Cell Lymphoma
A PHASE II TRIAL OF 2-CDA IN PREVIOUSLY TREATED OR UNTREATED PATIENTS WITH MANTLE CELL LYMPHOMA (MCL)
Status: Enrolling
Updated:  7/7/2015
CCOP - Toledo Community Hospital Oncology Program
mi
from
Toledo, OH
Cladribine in Patients With Mantle Cell Lymphoma
A PHASE II TRIAL OF 2-CDA IN PREVIOUSLY TREATED OR UNTREATED PATIENTS WITH MANTLE CELL LYMPHOMA (MCL)
Status: Enrolling
Updated: 7/7/2015
CCOP - Toledo Community Hospital Oncology Program
mi
from
Toledo, OH
Click here to add this to my saved trials
Cladribine in Patients With Mantle Cell Lymphoma
A PHASE II TRIAL OF 2-CDA IN PREVIOUSLY TREATED OR UNTREATED PATIENTS WITH MANTLE CELL LYMPHOMA (MCL)
Status: Enrolling
Updated:  7/7/2015
CCOP - Geisinger Clinical and Medical Center
mi
from
Danville, PA
Cladribine in Patients With Mantle Cell Lymphoma
A PHASE II TRIAL OF 2-CDA IN PREVIOUSLY TREATED OR UNTREATED PATIENTS WITH MANTLE CELL LYMPHOMA (MCL)
Status: Enrolling
Updated: 7/7/2015
CCOP - Geisinger Clinical and Medical Center
mi
from
Danville, PA
Click here to add this to my saved trials
Cladribine in Patients With Mantle Cell Lymphoma
A PHASE II TRIAL OF 2-CDA IN PREVIOUSLY TREATED OR UNTREATED PATIENTS WITH MANTLE CELL LYMPHOMA (MCL)
Status: Enrolling
Updated:  7/7/2015
Rapid City Regional Hospital
mi
from
Rapid City, SD
Cladribine in Patients With Mantle Cell Lymphoma
A PHASE II TRIAL OF 2-CDA IN PREVIOUSLY TREATED OR UNTREATED PATIENTS WITH MANTLE CELL LYMPHOMA (MCL)
Status: Enrolling
Updated: 7/7/2015
Rapid City Regional Hospital
mi
from
Rapid City, SD
Click here to add this to my saved trials
Cladribine in Patients With Mantle Cell Lymphoma
A PHASE II TRIAL OF 2-CDA IN PREVIOUSLY TREATED OR UNTREATED PATIENTS WITH MANTLE CELL LYMPHOMA (MCL)
Status: Enrolling
Updated:  7/7/2015
CCOP - Sioux Community Cancer Consortium
mi
from
Sioux Falls, SD
Cladribine in Patients With Mantle Cell Lymphoma
A PHASE II TRIAL OF 2-CDA IN PREVIOUSLY TREATED OR UNTREATED PATIENTS WITH MANTLE CELL LYMPHOMA (MCL)
Status: Enrolling
Updated: 7/7/2015
CCOP - Sioux Community Cancer Consortium
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Cladribine in Patients With Mantle Cell Lymphoma
A PHASE II TRIAL OF 2-CDA IN PREVIOUSLY TREATED OR UNTREATED PATIENTS WITH MANTLE CELL LYMPHOMA (MCL)
Status: Enrolling
Updated:  7/7/2015
Saskatchewan Cancer Agency
mi
from
Regina,
Cladribine in Patients With Mantle Cell Lymphoma
A PHASE II TRIAL OF 2-CDA IN PREVIOUSLY TREATED OR UNTREATED PATIENTS WITH MANTLE CELL LYMPHOMA (MCL)
Status: Enrolling
Updated: 7/7/2015
Saskatchewan Cancer Agency
mi
from
Regina,
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
Northeast Alabama Regional Medical Center
mi
from
Anniston, AL
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
Northeast Alabama Regional Medical Center
mi
from
Anniston, AL
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
Rebecca and John Moores UCSD Cancer Center
mi
from
La Jolla, CA
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
Rebecca and John Moores UCSD Cancer Center
mi
from
La Jolla, CA
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
Veterans Affairs Medical Center - San Diego
mi
from
San Diego, CA
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
Veterans Affairs Medical Center - San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
UCSF Comprehensive Cancer Center
mi
from
San Francisco, CA
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
UCSF Comprehensive Cancer Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
Veterans Affairs Medical Center - San Francisco
mi
from
San Francisco, CA
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
Veterans Affairs Medical Center - San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
CCOP - Christiana Care Health Services
mi
from
Newark, DE
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
CCOP - Christiana Care Health Services
mi
from
Newark, DE
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
Lombardi Cancer Center
mi
from
Washington,
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
Lombardi Cancer Center
mi
from
Washington,
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
Walter Reed Army Medical Center
mi
from
Washington,
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
Walter Reed Army Medical Center
mi
from
Washington,
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
Veterans Affairs Medical Center - Washington, DC
mi
from
Washington,
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
Veterans Affairs Medical Center - Washington, DC
mi
from
Washington,
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
Broward General Medical Center
mi
from
Fort Lauderdale, FL
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
Broward General Medical Center
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
Memorial Regional Hospital Comprehensive Cancer Center
mi
from
Hollywood, FL
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
Memorial Regional Hospital Comprehensive Cancer Center
mi
from
Hollywood, FL
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
Mount Sinai Medical Center CCOP
mi
from
Miami Beach, FL
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
Mount Sinai Medical Center CCOP
mi
from
Miami Beach, FL
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
Florida Hospital Cancer Institute
mi
from
Orlando, FL
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
Florida Hospital Cancer Institute
mi
from
Orlando, FL
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
Helen and Harry Gray Cancer Institute at Good Samaritan Medical Center
mi
from
West Palm Beach, FL
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
Helen and Harry Gray Cancer Institute at Good Samaritan Medical Center
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
Veterans Affairs Medical Center - Chicago Westside Hospital
mi
from
Chicago, IL
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
Veterans Affairs Medical Center - Chicago Westside Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
University of Chicago Cancer Research Center
mi
from
Chicago, IL
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
University of Chicago Cancer Research Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
Louis A. Weiss Memorial Hospital
mi
from
Chicago, IL
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
Louis A. Weiss Memorial Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
West Suburban Center for Cancer Care
mi
from
River Forest, IL
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
West Suburban Center for Cancer Care
mi
from
River Forest, IL
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
Saint Anthony Medical Center
mi
from
Rockford, IL
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
Saint Anthony Medical Center
mi
from
Rockford, IL
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
Fort Wayne Medical Oncology and Hematology, Incorporated
mi
from
Fort Wayne, IN
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
Fort Wayne Medical Oncology and Hematology, Incorporated
mi
from
Fort Wayne, IN
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
Hematology Oncology Associates of the Quad Cities
mi
from
Bettendorf, IA
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
Hematology Oncology Associates of the Quad Cities
mi
from
Bettendorf, IA
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
Holden Comprehensive Cancer Center
mi
from
Iowa City, IA
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
Holden Comprehensive Cancer Center
mi
from
Iowa City, IA
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
Baptist Hospital East - Louisville
mi
from
Louisville, KY
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
Baptist Hospital East - Louisville
mi
from
Louisville, KY
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
Marlene & Stewart Greenebaum Cancer Center, University of Maryland
mi
from
Baltimore, MD
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
Marlene & Stewart Greenebaum Cancer Center, University of Maryland
mi
from
Baltimore, MD
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
Veterans Affairs Medical Center - Baltimore
mi
from
Baltimore, MD
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
Veterans Affairs Medical Center - Baltimore
mi
from
Baltimore, MD
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
Dana-Farber Cancer Institute
mi
from
Boston, MA
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
University of Massachusetts Memorial Medical Center - University Campus
mi
from
Worcester, MA
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
University of Massachusetts Memorial Medical Center - University Campus
mi
from
Worcester, MA
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
Lakeland Medical Center - St. Joseph
mi
from
Saint Joseph, MI
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
Lakeland Medical Center - St. Joseph
mi
from
Saint Joseph, MI
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
Veterans Affairs Medical Center - Minneapolis
mi
from
Minneapolis, MN
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
Veterans Affairs Medical Center - Minneapolis
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
University of Minnesota Cancer Center
mi
from
Minneapolis, MN
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
University of Minnesota Cancer Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
Veterans Affairs Medical Center - Columbia (Truman Memorial)
mi
from
Columbia, MO
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
Veterans Affairs Medical Center - Columbia (Truman Memorial)
mi
from
Columbia, MO
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
Ellis Fischel Cancer Center - Columbia
mi
from
Columbia, MO
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
Ellis Fischel Cancer Center - Columbia
mi
from
Columbia, MO
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
Barnes Jewish Hospital
mi
from
Saint Louis, MO
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
Barnes Jewish Hospital
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
Washington University School of Medicine
mi
from
Saint Louis, MO
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
CCOP - Southern Nevada Cancer Research Foundation
mi
from
Las Vegas, NV
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
CCOP - Southern Nevada Cancer Research Foundation
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
Veterans Affairs Medical Center - Las Vegas
mi
from
Las Vegas, NV
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
Veterans Affairs Medical Center - Las Vegas
mi
from
Las Vegas, NV
Click here to add this to my saved trials